Patients with obesity disease and inadequately controlled body weight with diet and/or exercise

BMI ≥ 25 kg/m\^2 combined with at least two obesity-related comorbidities, or BMI ≥ 35 kg/m\^2 at least one obesity-related comorbidity

Patients with FPG ≥ 110 mg/dL and/or 5.6% ≤ HbA1c ≤ 10.0%, or T2DM with HbA1c ≤ 10.0%

Waist circumference at umbilical level ≥ 85 cm for male, ≥ 90 cm for female

Visceral fat area ≥ 100 cm\^2

Agreement to comply with the study-required life-style intervention and treatment during the full duration of the study

A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity